There are several treatment options currently available for adults with Type 2 Diabetes including insulin injections. Even so, 70-80% of people with T2D don’t have to take insulin while others have been diagnosed with T2D and have yet to begin insulin treatment.
If you qualify, you could help advance world medicine by using Continuous Glucose Monitoring (CGM) to determine Time in Range (TIR) of blood glucose or HbA1c levels in response to study medication.
Uncontrolled T2D could and very often does lead to heart disease, liver disease, kidney disease, stroke, and other conditions that progress slowly and silently. You can do something. See if you qualify for Type 2 Diabetes research studies today.
Tell us a little bit about yourself
Answer some questions about your health
We will connect you to available studies in your area
For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.
AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.